FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kjell Elgjo

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Concepts & Ideas

Genes & Molecular Sequences

Amino Acid Sequences

Anatomy

Procedures

Disorders

Skin Neoplasms

Co-author Network

Publications

TOP 3
Loretta Mancinelli; Paula M De Angelis; Lucia Annulli; Valentina Padovini; Kjell Elgjo; Gian Luigi Gianfranceschi
A class of DNA-binding peptides from wheat bud causes growth inhibition, G2 cell cycle arrest and apoptosis induction in HeLa cells.
Kjell Elgjo; Karl L Reichelt
Chalones: from aqueous extracts to oligopeptides.
Wenche H Reichelt; Jens-Gustav Iversen; Jan Erik Paulsen; Kjell Elgjo; Karl L Reichelt
Pyroglutamyl-histidyl-glycine, the endogenous colon mitosis inhibitor, regulates cyclic AMP level in non-tumorigenic colonic epithelial cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kjell Elgjo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Loretta Mancinelli; Paula M De Angelis; Lucia Annulli; Valentina Padovini; Kjell Elgjo; Gian Luigi Gianfranceschi
A class of DNA-binding peptides from wheat bud causes growth inhibition, G2 cell cycle arrest and apoptosis induction in HeLa cells.
Molecular cancer 2009;8():55.
2004: Kjell Elgjo; Karl L Reichelt
Chalones: from aqueous extracts to oligopeptides.
Cell cycle (Georgetown, Tex.) 2004;3(9):1208-11.
2004: Wenche H Reichelt; Jens-Gustav Iversen; Jan Erik Paulsen; Kjell Elgjo; Karl L Reichelt
Pyroglutamyl-histidyl-glycine, the endogenous colon mitosis inhibitor, regulates cyclic AMP level in non-tumorigenic colonic epithelial cells.
Anticancer research 2004;24(3a):1465-8.
2004: Wenche H Reichelt; Paula M de Angelis; Helle K Knutsen; Trine Husøy; Kjell Elgjo; Karl L Reichelt
The colon mitosis inhibitor pyroglutamyl-histidyl-glycine inhibits growth of non-tumorigenic colonic epithelial cells.
Anticancer research 2004;24(2B):587-91.
2003: Ying Liu; Wenche H Reichelt; Luisa Luna; Kjell Elgjo; Karl L Reichelt
The effects of a growth-inhibiting tripeptide, acetylGlu-Ser-GlyNH2 (Ac-ESG), on gene expression and cell cycle progression of two lymphoma cell lines.
Anticancer research 2003;23(4):3159-65.
2003: Wenche H Reichelt; Arne Yndestad; Marianne S Wright; Kjell Elgjo; Terje Haug; Karl L Reichelt
The colon mitosis-inhibitor pyroglutamyl-histidyl-glycine alters expression of immediate-early cancer-related genes in HT-29 cells.
Anticancer research 2003;23(2B):1229-34.
2002: Paal H H Lindenskov; Jan Erik Paulsen; Karl L Reichelt; Kjell Elgjo
Endogenous tetrapeptide from neuroblastoma and new-born pig brain inhibits neuroblastoma cell growth in vitro.
Anticancer research 2002;22(5):2847-51.
2001: Jan Erik Paulsen; Kjell Elgjo
Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor.
In vivo (Athens, Greece) 2001;15(5):397-401.
2001: Nils Eide; Per Syrdalen; David Scheie; Y Chen; Kjell Elgjo; Emilia Kerty; Knut Brabrand
Uveal melanomas with optic nerve extension: report of two cases diagnosed by transvitreal biopsy, one of them with a multicentric tumour.
Acta ophthalmologica Scandinavica 2001;79(3):322-5.
2000: Ying Liu; Kjell Elgjo; M Wright; Karl L Reichelt
Novel lymphocyte growth-inhibiting tripeptide: N-acetyl-glu-ser-GlyNH(2).
Biochemical and biophysical research communications 2000;277(3):562-7.
2000: Dmitry S Gembitsky; Paula M de Angelis; Karl L Reichelt; Kjell Elgjo
An endogenous melanocyte-inhibiting tripeptide pyroGlu-Phe-GlyNH2 delays in vivo growth of monoclonal experimental melanoma.
Cell proliferation 2000;33(2):91-9.
1998: Dmitry S Gembitsky; Karl L Reichelt; Kjell Elgjo
Antiproliferative effect of the tripeptide pyroGlu-Phe-GlyNH2 on murine melanocytes: transitory delay of cell growth in vitro and the cell cycle specificity.
Experimental cell research 1998;243(2):367-74.
1998: Kjell Elgjo; Karl L Reichelt; Dmitry S Gembitsky
Growth-inhibiting N-substituted endogenous peptides.
Progress in molecular and subcellular biology 1998;20():143-59.
1998: Dmitry S Gembitsky; Karl L Reichelt; P Haakonsen; Jan Erik Paulsen; Kjell Elgjo
Identification of a melanocyte growth-inhibiting tripeptide and determination of its structure.
The journal of peptide research : official journal of the American Peptide Society 1998;51(1):80-4.
1996: X L Wang; Kjell Elgjo; E Haaskjold
Regeneration of rat corneal epithelium is delayed by the inhibitory epidermal pentapeptide (EPP).
Acta ophthalmologica Scandinavica 1996;74(4):361-3.
1995: Kjell Elgjo; Karl L Reichelt; Wenche H Reichelt
Biologically active pyroglutamyl N-terminal oligopeptides: parts of larger molecules?
Physiological chemistry and physics and medical NMR 1995;27(4):351-3.
1995: Kjell Elgjo; Karl L Reichelt
Zinc and the mitosis-inhibitory epidermal pentapeptide (EPP) form a stimulatory chelated dimer.
Archives of dermatological research 1995;287(8):735-9.
1994: Kjell Elgjo; Karl L Reichelt
Beta-receptor blockade by propranolol modifies the effect of the inhibitory, endogenous epidermal pentapeptide on epidermal cell flux at the G2-M transition but not at the G1-S transition.
Epithelial cell biology 1994;3(1):32-7.
1993: O H Iversen; Kjell Elgjo; J E Paulsen; Karl L Reichelt
Moderate enhancement of the promotion phase of skin tumorigenesis in hairless mice by topical pretreatment with a mitosis-inhibiting epidermal pentapeptide.
Carcinogenesis 1993;14(12):2537-42.
1992: J E Paulsen; K S Hall; Hans Erik Rugstad; Karl L Reichelt; Kjell Elgjo
The synthetic hepatic peptides pyroglutamylglutamylglycylserylasparagine and pyroglutamylglutamylglycylserylaspartic acid inhibit growth of MH1C1 rat hepatoma cells transplanted into Buffalo rats or athymic mice.
Cancer research 1992;52(5):1218-21.
1991: J E Paulsen; K Sundby-Hall; L Endresen; Hans Erik Rugstad; Karl L Reichelt; Kjell Elgjo
The peptide pyroGlu-Gln-Gly-Ser-Asn, isolated from mouse liver, inhibits growth of rat hepatoma cells in vitro.
Carcinogenesis 1991;12(2):207-10.
1990: W M Olsen; Kjell Elgjo
UVB-induced epidermal hyperproliferation is modified by a single, topical treatment with a mitosis inhibitory epidermal pentapeptide.
The Journal of investigative dermatology 1990;94(1):101-6.
1990: Karl L Reichelt; J E Paulsen; Kjell Elgjo
Isolation of a growth and mitosis inhibitory peptide from mouse liver.
Virchows Archiv. B, Cell pathology including molecular pathology 1990;59(3):137-42.
1990: Kjell Elgjo; Karl L Reichelt
Mouse epidermal cell renewal after topical treatment with different concentrations of the epidermal peptide pyroGlu-Glu-Asp-Ser-GlyOH.
Virchows Archiv. B, Cell pathology including molecular pathology 1990;59(2):89-93.
1989: O H Iversen; Kjell Elgjo; Karl L Reichelt
Enhancement of methylnitrosourea-induced skin tumorigenesis and carcinogenesis in hairless mice by pretreatment with a mitosis-inhibiting epidermal pentapeptide.
Carcinogenesis 1989;10(2):241-4.
1988: Kjell Elgjo; Karl L Reichelt
Structure and function of growth inhibitory epidermal pentapeptide.
Annals of the New York Academy of Sciences 1988;548():197-203.